NASHVILLE, Tenn. (Ivanhoe Newswire) – It takes an average of 10 to 12 years and billions of dollars for a new drug to become FDA-approved. But what if that time and money could be much less? See how ...

Artificial Intelligence in Drug Repurposing Market · GlobeNewswire Inc. Dublin, Jan. 07, 2026 (GLOBE NEWSWIRE) -- The "Artificial Intelligence in Drug Repurposing Global Market Report 2025" has been ...

As of January 27, the global tally of SARS-CoV-2 infections has surpassed 100 million, with fatalities reaching 2 million. Remarkably, approximately 30 million confirmed cases remain untreated with ...

In a group of health-related headlines, one says "Hope for new drug approach. As government-supported research in the US is being decimated by funding cuts, it was refreshing to attend iDR25 (the ...

Mordor Intelligence has published a new report on Drug Repurposing Market offering a comprehensive analysis of trends, growth drivers, and future projections. Introduction: The drug repurposing market ...

Forbes contributors publish independent expert analyses and insights. Greg Licholai writes and teaches about innovation in healthcare. TxGNN is the first AI model specifically developed to identify ...

Drug repurposing and discovery represent a transformative approach in modern pharmacology, seeking to identify new therapeutic uses for existing, approved compounds while also uncovering novel drug ...

Old drugs, new ideas. That’s one of the core drivers of using artificial intelligence (AI) for drug development. Researchers using complex AI-fueled methods are now taking aim at what has become a ...

Scientists are using machine learning to find new treatments among thousands of old medicines. Scientists are using machine learning to find new treatments among thousands of old medicines. Joseph ...

Algorithms used for consumer predictions are being retooled to help identify which medicines are optimal and may carry hidden risks for patients. Researchers from Monash University used a different ...

Baritinib is a drug to treat rheumatoid arthritis. After outbreak of COVID-19, Benevolent AI Company discovered that AAK1 is a regulatory factor in the process of SARS-CoC-2 infection by generating a ...